Arrowhead Pharmaceuticals Inc.
ARWR
Market Cap$1.98B
Close$
$-3.99
130.1% downside
Current Fair Value
130.1% downsideOvervalued by 130.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.98 Billion |
|---|---|
| Enterprise Value | $2.04 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5 |
| Beta | 1 |
| Outstanding Shares | 124,848,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.81 |
|---|---|
| PEG | -5.07 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 575.07 |
| Enterprise Value to EBIT | -3.47 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 2.2 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Arrowhead Pharmaceuticals Inc.
CEO: Christopher Anzalone